GE Healthcare and ulrich medical announce an Agreement to Offer a Branded Multi-dose Contrast Media Injector in the U.S.

GE Healthcare has today announced an agreement with ulrich medical for a GE Healthcare branded contrast media injector in the U.S. The CT motion multi-dose syringeless injector, which delivers iodinated contrast media for Computed Tomography (CT) imaging procedures, reduces procedure setup time and increases patient throughput by eliminating time consuming preparation steps, while helping to optimize patient dosing and reduce wasted contrast media.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221125005300/en/

GE Healthcare branded CT Motion injector (Photo: Business Wire)

Recent research, led by Dushyant Sahani MD, Professor and Chair of Radiology at the University of Washington and presented at the 2022 Radiological Society of North America (RSNA) Congress, demonstrates that when compared to a typical dual-syringe based injector using single or multi-dose vials, the CT motion may enable six additional patient CT exams each day in a busy Emergency Department, with up to three minutes saved per patient. The research, which analyzed over 6,000 patients who received Contrast Enhanced CT or CT Angiography, also shows CT Motion reduces cost from consumables and saves an average 30 mL of contrast per procedure.

The U.S. contrast media injector market is estimated to grow at 4.3 percent annuallyⁱ between 2022-2030, attributed to its developed healthcare infrastructure and the prevalence of chronic diseases.

Today, the majority of contrast enhanced CT imaging involves radiology technicians filling a syringe with contrast media prior the injection procedure. With the syringeless CT motion, the required dose is drawn and injected directly from the injector’s contrast media container, saving time, facilitating the optimal volume of contrast media will be used, reducing wasted leftover contrast and generating less disposable waste. CT motion also provides injection reports accessible via RIS/PACS for dose management systems and records of prior injections to further optimize dose and improve patient safety.

Marco Campione, Americas General Manager at GE Healthcare Pharmaceutical Diagnostics said: “Radiology departments are focused on managing increasing demand and on conserving contrast media. The CT motion supports efficient operational practices - saving time, saving contrast, saving on consumables, improving workflows and facilitates better patient throughput. We expect demand for iodinated contrast media to double in the next decade, so we are investing, both in production capacity expansion and also in technologies like this that conserve volumes and reduce leftover contrast media.”